Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Condition(s):Lung Diseases; Lung Cancer, Protection AgainstLast Updated:February 21, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Lung Diseases; Lung Cancer, Protection AgainstLast Updated:February 21, 2024Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:May 12, 2016Withdrawn
Condition(s):Lung NeoplasmsLast Updated:February 28, 2024Recruiting
Condition(s):Lung CancerLast Updated:December 2, 2019Unknown status
Condition(s):Lung CarcinomaLast Updated:October 19, 2023Recruiting
Condition(s):Pulmonary MetastasesLast Updated:July 8, 2020Unknown status
Condition(s):Solitary Pulmonary Nodule; Multiple Pulmonary NodulesLast Updated:September 4, 2019Completed
Condition(s):AI (Artificial Intelligence); Pulmonary Nodule, Solitary; Pulmonary Nodule, Multiple; Lung CancerLast Updated:July 27, 2023Recruiting
Condition(s):Pulmonary Nodule; Lung Cancer; Lung DiseasesLast Updated:September 16, 2022Active, not recruiting
Condition(s):Pulmonary Nodule, Multiple; Pulmonary Nodule, SolitaryLast Updated:August 11, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.